NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

hoffman, DI has stated last November that they are in the peer-reviewing process. After he said they are being delayed (email Mike).

The only conclusion is thus that are stuck in peer-reviewing.
Also like I have said previously read sentiments and more important Vubru's posts from this week. Vubru has a lot of experience with the publication of medical articles in journals. He has said how long a normal peer review would take a timeline they have now widely crossed. The only conclusion there is to make is that thus they have run into problems in that process.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167713346

My guess regarding the delay in publication is they submitted a lot later than we thought and they are aiming high by sending initially to a good journal. The recent info about the Advisory Panel may help explain the delay (I've served on these before). These are usually one or two day events, invitation only ("key opinion leaders"), everyone signs an NDA, and they show the actual data and discuss it and how best to proceed. The consensus must have been that the company needs to do X, Y, and Z before announcing TLD and publishing. The fact that the company took this advice from the experts is not a bad thing. Even though the timing of TLD release by NWBO has been WAY outside the norm, I think it is being driven by the best information they have.